Megan M. Nichols

Ophthalmology

8600 Quivira Rd Ste 100
Lenexa, KS 66215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment-refractory neovascular age-related macular degeneration.

Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment-refractory neovascular age-related macular degeneration.

Journal: Indian journal of ophthalmology

Published: July 07, 2023

Showing 1-1 of 1

Last Updated: 09/26/2026